 |  |
| ABX | ||
| 3,009.681 | ||
| -10.1070 | -0.0033% | |
| BISNIS-27 | ||
| 538.674 | ||
| -5.2490 | -0.0097% | |
| DBX | ||
| 3,977.323 | ||
| -26.1000 | -0.0065% | |
| ECONOMIC30 | ||
| 113.238 | ||
| -1.0410 | -0.0091% | |
| ESGQKEHATI | ||
| 127.038 | ||
| -1.0660 | -0.0083% | |
| ESGSKEHATI | ||
| 127.837 | ||
| -0.8300 | -0.0065% | |
| I-GRADE | ||
| 217.497 | ||
| -1.8760 | -0.0086% | |
| AUDRP | ||
| 11,914.310 | ||
| -4.1300 | -0.0347% | |
| EURRP | ||
| 19,956.100 | ||
| -45.0900 | -0.2254% | |
| JPYRP | ||
| 109.898 | ||
| -0.4397 | -0.3985% | |
| SINRP | ||
| 13,324.620 | ||
| -21.1200 | -0.1583% | |
| USDRP | ||
| 16,821.000 | ||
| -32.0000 | -0.1899% | |
Penelitian terhadap vaksin nasional COVID-19, Vaksin Merah Putih, terus berlanjut, salah satunya oleh tim peneliti Universitas Airlangga bersama PT Biotis Pharmaceutical Indonesia. Penelitian vaksin telah memasuki uji praklinis tahap II.
